Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Ontology highlight
ABSTRACT: Inflammatory hepatocellular adenomas are benign liver tumours defined by the presence of inflammatory infiltrates and by the increased expression of inflammatory proteins in tumour hepatocytes. Here we show a marked activation of the interleukin (IL)-6 signalling pathway in this tumour type; sequencing candidate genes pinpointed this response to somatic gain-of-function mutations in the IL6ST gene, which encodes the signalling co-receptor gp130. Indeed, 60% of inflammatory hepatocellular adenomas harbour small in-frame deletions that target the binding site of gp130 for IL-6, and expression of four different gp130 mutants in hepatocellular cells activates signal transducer and activator of transcription 3 (STAT3) in the absence of ligand. Furthermore, analysis of hepatocellular carcinomas
SUBMITTER: Rebouissou S
PROVIDER: S-EPMC2695248 | biostudies-literature | 2009 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA